Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports
Sandeep M. Nayak, Natalie Gukasyan, Frederick S. Barrett, Earth Erowid, Fire Erowid, Roland R. Griffiths
Pharmacopsychiatry August 4, 2021 DOI: 10.1055/a-1524-2794 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Retrospective analysis of online reports Peer reviewed |
|---|---|
| Sample size | 96 |
| Population | Individuals reporting classic psychedelic use with mood stabilizers on Erowid.org, Shroomery.org, and Reddit.com |
| Intervention | LSD or psilocybin) |
| Keywords | Psychedelics Hallucinogens Entheogens Psychotropic drugs Medication interactions Pharmacodynamic interactions Drug-drug interactions Lithium Lamotrigine Seizure risk Epilepsy risk Convulsion danger Seizure potential Mood stabilizers Psychotropic medications Psychiatric drugs Mood-regulating agents |
| Citations | 67 |
| Key points | 47% of lithium plus psychedelic reports involved seizures, while none of the lamotrigine plus psychedelic reports did. |
Abstract
Abstract Introduction Psychedelics show promise in treating unipolar depression, though patients with bipolar disorder have been excluded from recent psychedelic trials. There is limited information on the use of classic psychedelics (e. g., LSD or psilocybin) in individuals using mood stabilizers to treat bipolar disorder. This is important to know, as individuals with bipolar depression may attempt to treat themselves with psychedelics while on a mood stabilizer, particularly given enthusiastic media reports of the efficacy of psilocybin for depression.
Methods: This study analyzed reports of classic psychedelics administered with mood stabilizers from 3 websites (Erowid.org, Shroomery.org, and Reddit.com).
Results: Strikingly, 47% of 62 lithium plus psychedelic reports involved seizures, and an additional 18% resulted in bad trips while none of 34 lamotrigine reports did. Further, 39% of lithium reports involved medical attention. Most of the lamotrigine reports (65%) but few (8%) of the lithium reports were judged to not affect the psychedelic experience.
Discussion: Although further research is needed, we provisionally conclude that psychedelic use may pose a significant seizure risk for patients on lithium.
Citations in the library
Cited by 66
- Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. Journal of Affective Disorders April 1, 2023
- Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey Frontiers in Psychiatry September 19, 2023
- Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review Psychopharmacology March 7, 2022
- Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research Psychopharmacology January 13, 2022
- Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption Journal of Psychopharmacology December 14, 2022
and 61 more in the library
Cites 16
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
and 11 more in the library